Published in Cancer Weekly, August 11th, 2009
"Between May 2004 and November 2005, 31 patients with pathologically proven stage IIIB/IV non-small cell lung cancer participated in this study. Metabolic response was assessed prospectively after one cycle of systemic therapy, which was compared with conventional radiographic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.